Home/Filings/4/0001415889-24-001542
4//SEC Filing

Pierce Valerie L 4

Accession 0001415889-24-001542

CIK 0001426332other

Filed

Jan 17, 7:00 PM ET

Accepted

Jan 18, 6:02 PM ET

Size

5.0 KB

Accession

0001415889-24-001542

Insider Transaction Report

Form 4
Period: 2024-01-16
Pierce Valerie L
SVP, GC & CCO
Transactions
  • Tax Payment

    Common Stock

    2024-01-16$1.34/sh5,021$6,72855,374 total
Footnotes (2)
  • [F1]Represents shares withheld by the issuer to satisfy the tax obligation realized in connection with the vesting of restricted stock units previously reported in Table 1.
  • [F2]Includes 4,728 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2023.

Issuer

NGM BIOPHARMACEUTICALS INC

CIK 0001426332

Entity typeother

Related Parties

1
  • filerCIK 0001397112

Filing Metadata

Form type
4
Filed
Jan 17, 7:00 PM ET
Accepted
Jan 18, 6:02 PM ET
Size
5.0 KB